financetom
Business
financetom
/
Business
/
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing
May 6, 2024 12:51 AM

03:20 AM EDT, 05/06/2024 (MT Newswires) -- Noubar Afeyan, Director, on May 01, 2024, sold 15,000 shares in Moderna ( MRNA ) for $1,663,855. Following the Form 4 filing with the SEC, Afeyan has control over a total of 11,692,969 shares of the company, with 2,026,931 shares held directly and 9,666,038 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1682852/000095017024053125/xslF345X03/ownership.xml

Price: 125.36, Change: +0.36, Percent Change: +0.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goodyear Tire & Rubber to Close Malaysia Plant on June 30
Goodyear Tire & Rubber to Close Malaysia Plant on June 30
Mar 8, 2024
07:24 AM EST, 03/08/2024 (MT Newswires) -- Goodyear Tire & Rubber ( GT ) plans to close its plant in Malaysia on June 30 as part of a restructuring program that targets $1 billion in cost reductions by 2025, according to reports published as early as Thursday. Reuters cited the company and Malaysia's investment promotion agency in its report. In...
Eve Holding Q4 Loss Widens
Eve Holding Q4 Loss Widens
Mar 8, 2024
07:40 AM EST, 03/08/2024 (MT Newswires) -- Eve Holding ( EVEX ) reported a Q4 loss Friday of $39.3 million, wider than $20.1 million a year earlier. A single analyst polled by Capital IQ expected a loss of $39.2 million. As expected, Eve did not report any revenue for the quarter ended Dec 31. The air mobility company had cash...
Numinus Wellness Notes MindMed's
Numinus Wellness Notes MindMed's "Positive" Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder
Mar 8, 2024
07:40 AM EST, 03/08/2024 (MT Newswires) -- Numinus Wellness Inc. ( NUMIF ) , a mental health care company advancing behavioral health treatments, on Friday noted positive data generated from Mind Medicine in its Phase 2b clinical trial of MM120 (lysergide d-tartrate) for the treatment of generalized anxiety disorder. The study removed variables such as additional medications and psychotherapy so...
Frontera Reports Lower EPS YOY In Q4 2023; Initiates Quarterly Dividend
Frontera Reports Lower EPS YOY In Q4 2023; Initiates Quarterly Dividend
Mar 8, 2024
07:33 AM EST, 03/08/2024 (MT Newswires) -- Frontera Energy Corp. ( FECCF ) reported overnight Thursday a diluted EPS of US$1.04 in the fourth quarter of 2023, falling year over year from US$2.25. Net sales dropped to US$232.2 million from US$237.6 million as total production was down to 39,267 barrels of oil equivalent per day (boe/d) from 41,806 boe/d. For...
Copyright 2023-2026 - www.financetom.com All Rights Reserved